Systematic review and network meta-analysis for the 2026 update of the evidence-based clinical practice guidelines for the management with immunosuppressive therapies and biologic agents of membranous nephropathy

Reiji Takami, Hiroki Nishiwaki, Yasushi Tsujimoto, Yuji Oe, Keisuke Onishi, Yuki Oba, Shinnosuke Sugihara, Yoshitaka Miyaoka, Mai Yoshida, Masahiko Yazawa, Tadashi Sofue, Izaya Nakaya, Takuji Ishimoto, Takehiko Kawaguchi, Noriaki Kurita, Sayaka Shimizu, Kengo Furuichi, Hirokazu Okada, Takehiko Wada

Open source

DOI: 10.1007/s10157-026-02944-4
Published: 2026-09-19
Container: Clinical and Experimental Nephrology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10157-026-02944-4,
  title = {Systematic review and network meta-analysis for the 2026 update of the evidence-based clinical practice guidelines for the management with immunosuppressive therapies and biologic agents of membranous nephropathy},
  author = {Reiji Takami and Hiroki Nishiwaki and Yasushi Tsujimoto and Yuji Oe and Keisuke Onishi and Yuki Oba and Shinnosuke Sugihara and Yoshitaka Miyaoka and Mai Yoshida and Masahiko Yazawa and Tadashi Sofue and Izaya Nakaya and Takuji Ishimoto and Takehiko Kawaguchi and Noriaki Kurita and Sayaka Shimizu and Kengo Furuichi and Hirokazu Okada and Takehiko Wada},
  year = {2026},
  journal = {Clinical and Experimental Nephrology},
  doi = {10.1007/s10157-026-02944-4},
  url = {https://doi.org/10.1007/s10157-026-02944-4}
}

RIS

TY  - JOUR
TI  - Systematic review and network meta-analysis for the 2026 update of the evidence-based clinical practice guidelines for the management with immunosuppressive therapies and biologic agents of membranous nephropathy
AU  - Reiji Takami
AU  - Hiroki Nishiwaki
AU  - Yasushi Tsujimoto
AU  - Yuji Oe
AU  - Keisuke Onishi
AU  - Yuki Oba
AU  - Shinnosuke Sugihara
AU  - Yoshitaka Miyaoka
AU  - Mai Yoshida
AU  - Masahiko Yazawa
AU  - Tadashi Sofue
AU  - Izaya Nakaya
AU  - Takuji Ishimoto
AU  - Takehiko Kawaguchi
AU  - Noriaki Kurita
AU  - Sayaka Shimizu
AU  - Kengo Furuichi
AU  - Hirokazu Okada
AU  - Takehiko Wada
PY  - 2026
JO  - Clinical and Experimental Nephrology
DO  - 10.1007/s10157-026-02944-4
UR  - https://doi.org/10.1007/s10157-026-02944-4
ER  -

APA

Takami, R., Nishiwaki, H., Tsujimoto, Y., Oe, Y., Onishi, K., Oba, Y., Sugihara, S., Miyaoka, Y., Yoshida, M., Yazawa, M., Sofue, T., Nakaya, I., Ishimoto, T., Kawaguchi, T., Kurita, N., Shimizu, S., Furuichi, K., Okada, H., & Wada, T. (2026). Systematic review and network meta-analysis for the 2026 update of the evidence-based clinical practice guidelines for the management with immunosuppressive therapies and biologic agents of membranous nephropathy. Clinical and Experimental Nephrology. https://doi.org/10.1007/s10157-026-02944-4

Source records

crossref · retrieved 2026-09-25T23:48:39.187Z